The metabolome: A way to measure obesity and health beyond BMI

October 11, 2018

The link between obesity and health problems may seem apparent. People who are obese are at higher risk of type 2 diabetes, liver disease, cancer, and heart disease. But increasingly, researchers are learning that the connection is not always clear-cut. For this reason, they've sought to develop better ways to determine who is at an elevated risk of developing these complications.

The current standard for determining obesity is body mass index (BMI), a simple mathematical formula that uses weight and height. Now a paper appearing October 11 in the journal Cell Metabolism is reporting a large study of new ways to measure obesity. The study looked at both the metabolome and the genome, and their relationship to BMI.

"We are attempting to identify the heterogeneity in what we currently call obesity. There's a need for more precise ways of measuring," says senior author Amalio Telenti (@atelentia), a genomics professor at Scripps Research. "Although it's clear that obesity is linked to certain diseases, not everybody who is obese will have these consequences. Also surprising, you may not look obese but still have the problems of someone who is."

The metabolome is the sum of all the small-molecule chemicals found in a biological sample, often the blood plasma. These chemicals include fatty acids, amino acids, sugars, and vitamins, to name a few. The metabolome changes in response to interactions between the genome and the environment. Those who study metabolomics say it's poised to become an important part of personalized medicine, along with genomics, proteomics, and analysis of the microbiome.

In the current study, the investigators used data from TwinsUK, a multiyear study examining the genetic and environmental influences on human health and aging. They analyzed body and metabolic measures from nearly 2,000 adult twins that had been collected at three time points over an average of 13 years. They also used data from a single time point for 427 volunteers. They found that about one-third of the metabolites included in the study were associated with changes in BMI.

"For most people, we found the metabolome is tied very closely to weight and BMI," Telenti explains. "Every time someone gains or loses a pound, their metabolome changes. It's almost linear." But at the same time, he adds, "correlating well is not the same as correlating perfectly, and that's where this work became very interesting."

"There have been studies before of individuals whose BMI doesn't match their metabolic health, but this is a new way of defining who is metabolically healthy," says first author Liz Cirulli (@ETCirulli), a research scientist at Human Longevity Inc. "All across the weight spectrum, we found people who were heavier or lighter than expected based on their metabolome." These differences were found in a range of metabolites linked to various diseases.

A surprising finding was that genetics didn't correlate nearly as closely as expected. Differences in genetics between obese and non-obese populations didn't show patterns that were distinct enough to be predictive. The exception was with a few particular genes known to be connected with extreme obesity, such as mutations in MC4R. This gene is known to play a critical role in regulating food intake and energy balance.

Telenti stresses that the metabolome tests developed for this paper are still an academic development, and much more research is needed before they can be validated and established for clinical use. But eventually, the hope is that it will be possible for someone to get a comprehensive analysis of all the metabolites in their body with one blood test, rather than the battery of tests that's currently part of a standard physical exam.

Cirulli says that future work will look at defining metabolic signatures for other traits, including blood pressure and android/gynoid ratios--a measure of different types of body fat. In addition, she explains, "It's important to collect additional longitudinal data in bigger cohorts to see what the long-term health consequences of different metabolic states are."
-end-
This research was funded by a National Institutes of Health Center for Translational Science Award and Human Longevity Inc. Twins UK receives funding from the Wellcome Trust. The study also received funding from the European Community's Seventh Framework Programme; the National Institute for Health Research (NIHR) Clinical Research Facility at Guy's & St Thomas' NHS Foundation Trust; and NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London.

Cell Metabolism, Cirulli et al. "Profound perturbation of the metabolome in obesity associates with health risk." http://www.cell.com/cell-metabolism/fulltext/S1550-4131(18)30630-2

Cell Metabolism (@Cell_Metabolism), published by Cell Press, is a monthly journal that publishes reports of novel results in metabolic biology, from molecular and cellular biology to translational studies. The journal aims to highlight work addressing the molecular mechanisms underlying physiology and homeostasis in health and disease. Visit: http://www.cell.com/cell-metabolism. To receive Cell Press media alerts, contact press@cell.com.

Cell Press

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.